Standard

The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men : A mathematical modelling study. / Xiridou, Maria; Adam, Philippe; Meiberg, Annemarie et al.

In: Vaccine, Vol. 40, No. 33, 05.08.2022, p. 4889-4896.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Vancouver

Xiridou M, Adam P, Meiberg A, Visser M, Matser A, de Wit J et al. The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study. Vaccine. 2022 Aug 5;40(33):4889-4896. Epub 2022. doi: 10.1016/j.vaccine.2022.06.075

Author

Xiridou, Maria ; Adam, Philippe ; Meiberg, Annemarie et al. / The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men : A mathematical modelling study. In: Vaccine. 2022 ; Vol. 40, No. 33. pp. 4889-4896.

BibTeX

@article{3cb346e905a4486bb0a498219171aa3d,
title = "The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study",
abstract = "Background: During the COVID-19 pandemic, the number of hepatitis B virus (HBV) vaccinations among men who have sex with men (MSM) has been considerably lower than before the pandemic. Moreover, less frequent HBV testing and a reduction in numbers of sex partners have been reported. We assessed the impact of these COVID-19-related changes on HBV transmission among MSM in the Netherlands. Methods: We estimated the changes in sexual activity, HBV testing, and HBV vaccination among MSM during the pandemic from Dutch data. We used a deterministic compartmental model and investigated scenarios with small or large declines in sexual activity, testing, and vaccination for the current phase of the pandemic (without available data). We examined the increase in HBV vaccinations needed to prevent further increase in HBV incidence. Results: With a decrease in numbers of sex partners of 15–25% during the first lockdown and 5% during the second lockdown, we found a decline of 6.6% in HBV incidence in 2020, despite a >70% reduction in HBV testing and vaccination during the first lockdown. With numbers of sex partners rebounding close to pre-pandemic level in 2021, and a reduction of 15% in testing and 30% in vaccination in 2021, we found an increase of 1.4% in incidence in 2021 and 3.1% in 2026. With these changes, an increase of ≥60% in HBV vaccinations in 2022 would be needed to bring the HBV incidence in 2023 back to the level that it would have had if the COVID-19-related changes had not occurred. Conclusions: Despite reductions in sexual activity during the COVID-19 pandemic, the decrease in HBV vaccinations may result in a small increase in HBV incidence after 2021, which may persist for years. It is important to restore the vaccination level and limit further increase in HBV transmission among MSM.",
keywords = "COVID-19, Hepatitis B virus, Mathematical model, Men who have sex with men, Sexual behaviour, Vaccination",
author = "Maria Xiridou and Philippe Adam and Annemarie Meiberg and Maartje Visser and Amy Matser and {de Wit}, John and {op de Coul}, Eline",
note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",
year = "2022",
month = aug,
day = "5",
doi = "10.1016/j.vaccine.2022.06.075",
language = "English",
volume = "40",
pages = "4889--4896",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "33",

}

RIS

TY - JOUR

T1 - The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men

T2 - A mathematical modelling study

AU - Xiridou, Maria

AU - Adam, Philippe

AU - Meiberg, Annemarie

AU - Visser, Maartje

AU - Matser, Amy

AU - de Wit, John

AU - op de Coul, Eline

N1 - Publisher Copyright: © 2022 Elsevier Ltd

PY - 2022/8/5

Y1 - 2022/8/5

N2 - Background: During the COVID-19 pandemic, the number of hepatitis B virus (HBV) vaccinations among men who have sex with men (MSM) has been considerably lower than before the pandemic. Moreover, less frequent HBV testing and a reduction in numbers of sex partners have been reported. We assessed the impact of these COVID-19-related changes on HBV transmission among MSM in the Netherlands. Methods: We estimated the changes in sexual activity, HBV testing, and HBV vaccination among MSM during the pandemic from Dutch data. We used a deterministic compartmental model and investigated scenarios with small or large declines in sexual activity, testing, and vaccination for the current phase of the pandemic (without available data). We examined the increase in HBV vaccinations needed to prevent further increase in HBV incidence. Results: With a decrease in numbers of sex partners of 15–25% during the first lockdown and 5% during the second lockdown, we found a decline of 6.6% in HBV incidence in 2020, despite a >70% reduction in HBV testing and vaccination during the first lockdown. With numbers of sex partners rebounding close to pre-pandemic level in 2021, and a reduction of 15% in testing and 30% in vaccination in 2021, we found an increase of 1.4% in incidence in 2021 and 3.1% in 2026. With these changes, an increase of ≥60% in HBV vaccinations in 2022 would be needed to bring the HBV incidence in 2023 back to the level that it would have had if the COVID-19-related changes had not occurred. Conclusions: Despite reductions in sexual activity during the COVID-19 pandemic, the decrease in HBV vaccinations may result in a small increase in HBV incidence after 2021, which may persist for years. It is important to restore the vaccination level and limit further increase in HBV transmission among MSM.

AB - Background: During the COVID-19 pandemic, the number of hepatitis B virus (HBV) vaccinations among men who have sex with men (MSM) has been considerably lower than before the pandemic. Moreover, less frequent HBV testing and a reduction in numbers of sex partners have been reported. We assessed the impact of these COVID-19-related changes on HBV transmission among MSM in the Netherlands. Methods: We estimated the changes in sexual activity, HBV testing, and HBV vaccination among MSM during the pandemic from Dutch data. We used a deterministic compartmental model and investigated scenarios with small or large declines in sexual activity, testing, and vaccination for the current phase of the pandemic (without available data). We examined the increase in HBV vaccinations needed to prevent further increase in HBV incidence. Results: With a decrease in numbers of sex partners of 15–25% during the first lockdown and 5% during the second lockdown, we found a decline of 6.6% in HBV incidence in 2020, despite a >70% reduction in HBV testing and vaccination during the first lockdown. With numbers of sex partners rebounding close to pre-pandemic level in 2021, and a reduction of 15% in testing and 30% in vaccination in 2021, we found an increase of 1.4% in incidence in 2021 and 3.1% in 2026. With these changes, an increase of ≥60% in HBV vaccinations in 2022 would be needed to bring the HBV incidence in 2023 back to the level that it would have had if the COVID-19-related changes had not occurred. Conclusions: Despite reductions in sexual activity during the COVID-19 pandemic, the decrease in HBV vaccinations may result in a small increase in HBV incidence after 2021, which may persist for years. It is important to restore the vaccination level and limit further increase in HBV transmission among MSM.

KW - COVID-19

KW - Hepatitis B virus

KW - Mathematical model

KW - Men who have sex with men

KW - Sexual behaviour

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85133776600&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2022.06.075

DO - 10.1016/j.vaccine.2022.06.075

M3 - Article

C2 - 35810058

VL - 40

SP - 4889

EP - 4896

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 33

ER -

ID: 25073437